Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.

Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.

http://www.wikidata.org/entity/Q39920144

about

Evidence for irreversible inhibition of glycogen synthase kinase-3β by tideglusib The regulation and deregulation of Wnt signaling by PARK genes in health and disease GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals Targeting protein kinases in central nervous system disorders DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau.ProphNet: a generic prioritization method through propagation of information GSK3 and Alzheimer's Disease: Facts and Fiction….Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes Common polymorphism in the MMP-13 gene may contribute to the risk of human cancers: a meta-analysis.Common Polymorphisms in the GSK3β Gene May Contribute to the Pathogenesis of Alzheimer Disease: A Meta-Analysis.Candidate gene resequencing to identify rare, pedigree-specific variants influencing healthy aging phenotypes in the long life family study.Glycogen synthase kinase 3: a point of integration in Alzheimer's disease and a therapeutic target?Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.The importance of brain banks for molecular neuropathological research: The New South Wales Tissue Resource Centre experience Glycogen synthase kinase-3β: a mediator of inflammation in Alzheimer's disease?Role of epigenetics in Alzheimer's and Parkinson's disease.Lessons from genome-wide association studies findings in Alzheimer's disease.Understanding the relationship between GSK-3 and Alzheimer's disease: a focus on how GSK-3 can modulate synaptic plasticity processes.The role of cholesterol metabolism in Alzheimer's disease.TMEM158 and FBLP1 as novel marker genes of cisplatin sensitivity in non-small cell lung cancer cells.Wild type and P301L mutant Tau promote neuro-inflammation and α-Synuclein accumulation in lentiviral gene delivery models.Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer's disease.Regulation of cell survival mechanisms in Alzheimer's disease by glycogen synthase kinase-3 Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial.Kidins220 accumulates with tau in human Alzheimer's disease and related models: modulation of its calpain-processing by GSK3β/PP1 imbalance.An Association Study Between Genetic Polymorphisms in Functional Regions of Five Genes and the Risk of Schizophrenia.The association between single nucleotide polymorphisms of GSK 3β gene and sporadic Alzheimer's disease in a cohort of southern Chinese Han population.Global Approaches to Understanding Protein Kinase Functions Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review

P2860

Q24610904-A57E0572-2936-4851-B566-B4C8E18FD3E6 Q26991986-F926FC88-7B66-4C5D-800B-1FB237F4C07B Q28535250-3D448584-0B55-4B11-B13D-7072D8419B12 Q33671660-507908A2-DBFC-4328-A440-2BEBEA4322E3 Q33818001-49E86B2C-FD1E-4DB4-BC78-1CCCF5A11CB3 Q33986970-80457A61-4A93-4624-801A-1A881B05D22C Q35065979-3A75AF2D-15E9-49A7-B6FC-4B61EE06A45C Q35101468-1387256E-202A-4D04-B8E2-3FBEA3E2BDB7 Q35182282-AA5028BF-867A-4926-9469-7DF4EC9BE69E Q35191233-7BE12A2B-E732-4FFA-A919-B2756B005A4A Q35206743-90257C50-28D2-4053-9E83-83EEFB103324 Q35373154-679E89B5-0370-46A5-941C-2AB1937F9854 Q35984424-8EF05F05-5863-4BA9-A880-701796DD44D4 Q36063447-D543ECB0-7D97-4A49-861D-CF307146DEBB Q36644694-B720D756-8FFF-40F8-8649-D3CB753E5CC1 Q36758618-D41CACBA-208B-4168-861C-00BAA96105F2 Q37143169-75484DF2-6BBA-435C-B56A-5DF63E2E11B9 Q37883104-B3AEFD8A-2BF0-4AE4-90FF-8B609B45F8DA Q37961788-9C92DEC6-2691-4A9E-835F-F729A0CE2FC9 Q37993591-2B0798D0-BB9B-4CFC-8D4D-F78226E5D59A Q38101982-00766127-3208-427C-B4EE-7F886B08452D Q38212604-2FA971B8-922F-4F83-A609-58AFE068B795 Q39253575-8D375E49-0B4F-48EC-8491-A2927BFBD4F4 Q39994322-76E58B9B-F0BC-41BF-BB77-2D7928AE7068 Q41438444-D8BB9EF6-828F-43B7-8C20-E7A3431A9B6F Q42102101-92DEBFAE-0E63-4C5B-A2CD-F5F943698A6C Q47979421-4E7F8F82-EDF6-455A-9D8E-3A9F054191E9 Q48311391-49C19EA8-8346-4DD6-9CCB-306064DF81EE Q50533627-CD32EDF6-4157-40C8-B9EC-2C97A018FD7E Q54194186-75993509-FE22-463D-A827-B48FEFA0774D Q57833109-923871BA-834C-4C1F-A5FC-7EFA3E199F21 Q58549216-ACBB74DD-F3CF-41D1-B4CD-94DB1646222E

P2860

Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.

http://www.wikidata.org/entity/Q39920144

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.

@en

Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.

@nl

type

label

Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.

@en

Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.

@nl

prefLabel

Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.

@en

Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.

@nl

P1433

Q39920144-359895A5-DB95-43BB-B091-2B38CA7BE524

P1476

Q39920144-875CFC42-4C7C-432E-9377-C95F9002B5A2

P2093

Q39920144-0890FE0F-CA41-4C5A-B996-1FE93656F9FF

Q39920144-36BD352F-85A6-404B-B5DA-7F97929B1357

Q39920144-41BC040F-B63B-42FB-A485-B017FAF51220

Q39920144-4358618C-1B4A-4806-A62A-CE9759714C1F

Q39920144-46335889-7C33-4274-88F9-C94BB72479EE

Q39920144-AD44C122-9696-4129-B256-1C800521E293

Q39920144-CCC6ED37-CDBE-4CEA-ABBF-16789FCFE898

Q39920144-F6089C5C-9814-4F51-9D44-0CC09682FAED

Q39920144-F712C6FC-5260-423A-9E42-1762D7A7EA72

P2860

Q39920144-00E5E144-F532-4614-9A4F-91C3758C4E2B

Q39920144-0104FB30-76C8-441F-AD42-7A5B68D5B58D

Q39920144-048D775F-83F1-434D-9688-9E199138D7EA

Q39920144-16700A0E-B301-49C8-A5DA-991F766633A4

Q39920144-20FCE880-E43B-4062-9595-EDB09290126D

Q39920144-27C80153-DB27-4FF7-AE4D-904B1B038B7C

Q39920144-33DB51CF-A308-4B4D-A02D-7DB98E75B707

Q39920144-3E6D078B-AA30-4AB0-9670-D2CF20FD55A6

Q39920144-44A9FC4E-DA60-44DD-AF11-88086BFAB69C

Q39920144-4DDE0C1D-2C2D-49D2-A434-84AD00B1EC06

P304

Q39920144-F1014C9B-A62E-4219-B02B-C900C01B83BD

P31

Q39920144-DC48D2ED-52EA-46EB-81D2-313E104C866A

P356

Q39920144-1E54FFB5-3237-43F7-B5C0-B3EF339F3E91

P433

Q39920144-45720DF4-96C9-44A3-880F-AB38355BC732

P478

Q39920144-C501A63B-1390-4B48-B2C5-682E4A1F797B

P50

Q39920144-1361F9A3-2F87-4844-8A28-B282470F0C4C

Q39920144-5CAE6EA0-3A69-425C-B75E-EDA7EB38FC92

Q39920144-91D574AE-CA0E-48DB-9591-6CDED35E2C87

Q39920144-D4E604F9-817C-41A6-8628-2A71D9ABD179

P577

Q39920144-AD206541-2328-4AF6-9DB8-DEF5A2E3A2EF

P5875

Q39920144-D9A1096D-744E-4858-A58A-E90FD885B771

P698

Q39920144-826CD716-E1A6-4829-A944-A7130C1462DF

P921

Q39920144-C2905565-867C-4664-860C-9CDD31CC7A9C

P356

P1433

Annals of Neurology

P1476

Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.

@en

P2093

Clement T Loy

http://www.w3.org/2001/XMLSchema#string

Edmond Lau

http://www.w3.org/2001/XMLSchema#string

G Anthony Broe

http://www.w3.org/2001/XMLSchema#string

Gillian Hamilton

http://www.w3.org/2001/XMLSchema#string

John B J Kwok

http://www.w3.org/2001/XMLSchema#string

John F Powell

http://www.w3.org/2001/XMLSchema#string

Julie Williams

http://www.w3.org/2001/XMLSchema#string

Marianne Hallupp

http://www.w3.org/2001/XMLSchema#string

Michael J Owen

http://www.w3.org/2001/XMLSchema#string

P2860

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

A New Statistical Method for Haplotype Reconstruction from Population Data

GSK3B polymorphisms alter transcription and splicing in Parkinson's disease

Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis

Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population

Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c.SRp55 complex that either recruits or antagonizes htra2beta1

The glamour and gloom of glycogen synthase kinase-3

Haplotype-specific expression of exon 10 at the human MAPT locus.

Functions and malfunctions of the tau proteins.

Alzheimer's disease and Parkinson's disease.

P304

446-454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.21476

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

Simon Lovestone

Nelson Leung-Sang Tang

Peter R Schofield

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23458545

http://www.w3.org/2001/XMLSchema#string

P698

18991351

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease